Accent Microcell Ltd vs Chandra Bhagat Pharma Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 03, 2026

Key Highlights

The Latest Trading Price of Accent Microcell Ltd is ₹ 425.35 as of 30 Apr 15:30 . The P/E Ratio of Accent Microcell Ltd changed from 17.1 on March 2024 to 12.1 on March 2025 . This represents a CAGR of -15.88% over 2 yearsThe P/E Ratio of Chandra Bhagat Pharma Ltd changed from 158.4 on March 2021 to 45.9 on March 2025 . This represents a CAGR of -21.94% over 5 years The Market Cap of Accent Microcell Ltd changed from ₹ 517.13 crore on March 2024 to ₹ 401.61 crore on March 2025 . This represents a CAGR of -11.87% over 2 yearsThe Market Cap of Chandra Bhagat Pharma Ltd changed from ₹ 29.88 crore on March 2021 to ₹ 39.48 crore on March 2025 . This represents a CAGR of 5.73% over 5 years The Dividend Payout of Accent Microcell Ltd changed from 8.96 % on March 2021 to 6.36 % on March 2025 . This represents a CAGR of -6.63% over 5 yearsThe Dividend Payout of Chandra Bhagat Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Accent Microcell Ltd

Accent Microcell Limited was originally incorporated on April 10, 2012 as a Private Limited Company as 'Accent Microcell Private Limited' with the Registrar of Companies, Gujarat.
The Company converted from a Private Limited Company to Public Limited Company and , the name was changed to Accent Microcell Limited' and a Fresh Certificate of Incorporation was issued on December 23, 2022 by the Registrar of Companies, Ahmedabad. Presently, the Company manufacture Microcrystalline Cellulose (MCC) consisting Spray Dryer / Spin Flash Dried.
The Company is engaged in manufacturing of the high-quality cellulose-based excipients which predominantly find application in the Pharmaceutical, Nutraceutical, Food, Cosmetic and other industries. With 2 state-of-art manufacturing facilities located in Pirana (Unit -I) and Dahej SEZ (Unit -II).

About Chandra Bhagat Pharma Ltd

Chandra Bhagat Pharma Limited was incorporated as a Private Limited Company with the name 'Chandra Bhagat Pharma Private Limited' at Mumbai on March 10, 2003.
Consequent upon the conversion of the Company from Private Limited Company to Public Limited Company, the name of the Company was changed to 'Chandra Bhagat Pharma Limited' on March 20, 2019. The Company incorporated in March, 2003 by Mr. Hemant Bhagat and Late.
Shree Chandravadan Bhagat.
On April 1, 2003, the Company acquired the going concern business of M/s.
Chandra Bhagat Corporation, partnership firm along with all its assets and liabilities.

FAQs for the comparison of Accent Microcell Ltd and Chandra Bhagat Pharma Ltd

Which company has a larger market capitalization, Accent Microcell Ltd or Chandra Bhagat Pharma Ltd?

Market cap of Accent Microcell Ltd is 1,020 Cr while Market cap of Chandra Bhagat Pharma Ltd is 24 Cr

What are the key factors driving the stock performance of Accent Microcell Ltd and Chandra Bhagat Pharma Ltd?

The stock performance of Accent Microcell Ltd and Chandra Bhagat Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Accent Microcell Ltd and Chandra Bhagat Pharma Ltd?

As of May 3, 2026, the Accent Microcell Ltd stock price is INR ₹425.35. On the other hand, Chandra Bhagat Pharma Ltd stock price is INR ₹33.0.

How do dividend payouts of Accent Microcell Ltd and Chandra Bhagat Pharma Ltd compare?

To compare the dividend payouts of Accent Microcell Ltd and Chandra Bhagat Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.